Lepu Biopharma Co., Ltd. (stock code: 02157) released its monthly return for the period ended 31 January 2026. The announcement indicates that the company’s authorized share capital remained at 1,804,439,838 ordinary shares with a par value of RMB 1 each. There was no increase or decrease during the month, and the total authorized share capital stayed at RMB 1,804,439,838.

The number of issued shares also remained unchanged at 1,804,439,838, with no treasury shares held. According to the return, the public float requirement was met without any shortfall. The announcement further notes there were no new share options, warrants, convertibles, or other share-issuing arrangements introduced in this reporting period.